HASYUN® Oral tablets
Anti-inflammatory and anti-allergic.
As a treatment in hypersensitive disorders such as state of shock; in immune disease treatments such as for Pemphigus; in serious cases of dermatitis and systemic lupus erythematosus; musculoskeletal disorders; allergies and hypoadrenocorticism.
Technical Specification
Species
Dogs and cats.
Dosage form
Oral tablet .
Therapeutic action
Anti-inflammatory and anti-allergic.
Composition
Each tablet contains:
Dexamethasone..................025 mg
Excipients q.s.p...................1 tablet
Indications
As a treatment in hypersensitive disorders such as state of shock; in immune disease treatments such as for Pemphigus; in serious cases of dermatitis and systemic lupus erythematosus; musculoskeletal disorders; allergies and hypoadrenocorticism.
Route od administration and dosage
Oral route.
Product dose: Anti-inflammatory – Anti allergic:
- Dogs: 1 to 4 tablets (0.25 to 1 mg) daily, for 7 days
- Cats: ½ to 2 tablets (0.125 to 0.5 mg) daily, for 7 days.
Drug interactions
- Concomitant administration with Amphotericin B or caliuretic diuretics (Furosemide, thiazides) can cause hypokalemia.
- When both drugs are used together with digitalis glycosides, the possibility of toxicity can be increased if hypokalemia is generated.
- Dexamethasone can lower blood levels of salicylates.
- Insulin requirements may increase in patients receiving Dexamethasone.
- Phenytoin, Phenobarbital and Rifampicin can increase glucocorticoid metabolism.
- Concomitant administration with Cyclosporine can increase the blood levels of both drugs, with mutual inhibition of liver metabolism.
- Concomitant administration with ulcerogenic drugs (eg, non-steroidal anti-inflammatory drugs) may increase the risk of gastrointestinal ulceration.
- Patients treated with corticosteroids at immunosuppressive doses should not receive live attenuated virus vaccines, as they may enhance viral replication.
Contraindications
- Do not use in pregnant females.
- Do not use in patients with gastric or duodenal ulcers.
- Do not use in animals with corneal ulcer.
- Do not use in patients with Diabetes Mellitus or Cushing's Syndrome.
Special precautions for the operator
Wash hands after administering the product.
Warnings
Special warnings and precautions for use:
- Keep out of the reach of children.
- In case of prolonged therapy (more than 7 days) it should be gradually discontinued in successive days according to what is indicated by the treating Veterinary Doctor.
Adverse effects
Adverse effects and adverse reactions:
It can cause polyphagia, polyuria, and polydipsia, delay wound healing, weaken resistance to infections, or exacerbate existing infections. In prolonged treatments it can cause iatrogenic hyperadrenocorticism (Cushing's Syndrome), with loss of muscle mass, weakness, weight gain with fat redistribution, osteoporosis and ulcers.
Observations
Special precautions for the disposal of unused product or waste material:
Do not dispose of containers with product residues on the ground or water courses. Empty containers can be discarded as household waste, without any special precautions. For expired or unused products, contact the manufacturing laboratory.
Conservation
Keep in a cool and dry place, at room temperature between 15 ° and 30° C.
Condition of sale
To be supply only on veterinary prescription.
Presentation
Case with 10 tablets.
Prepared by
Drag Pharma Laboratory.
Records
- Chile: Reg. SAG No.: 0527
- Uruguay: Reg. No. MGAP A-4494
Countries where it is marketed
Imported and distributed in Bolivia by:
ZOOFARMA
TEL: +(591)222-3357
Street Díaz Romero 1339, La Paz.
Related products
You have entered drug info or veterinary products intended exclusively (s) kind (s) indicated (s).
Drag Pharma Lab is not responsible for the consequences of misuse of the products, and the use of this information without consulting a veterinarian